Navigation Links
Issuer Ratings, Recognitions, Positive Clinical Results, and Quarterly Dividends - Research Report on Pfizer, UnitedHealth, Merck, Gilead, and Bristol-Myers
Date:9/20/2013

rop="name">Dottie Brienza, Chief Diversity Officer and Executive Talent Leader, Merck, said, "This award recognizes Merck's commitment to fostering an environment where all employees, including working parents and those who provide care for others, can effectively integrate work and life, take care of themselves and their families and reach their professional goals." According to the Company, this recognition marks the 26th year that Merck was honored on the Working Mother 100 Best Companies List. The Full Research Report on Merck & Co., Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/430d_MRK]

--

Gilead Sciences, Inc. Research Report

On September 12, 2013, Gilead Sciences Inc. (Gilead) announced 48-week results from a Phase 2 study (Study 102) evaluating tenofovir alafenamide (TAF), an investigational once-daily single tablet regiment, for the treatment of HIV-1 infection. The Company revealed that at 48 weeks, a regimen of elvitegravir 150mg/cobicistat 150 mg/emtricitabine 200 mg/TAF 10mg was found to be similar to Stribild (elvitegravir 150mg/cobicistat 150mg/emtricitabine 200mg/tenofovir disoproxil fumarate 300 mg) based on the percentage of patients with HIV RNA levels less than 50 copies/mL, and was associated with more favorable renal and bone safety markers. Norbert W. Bischofberger, PhD, Gilead's Executive Vice President, Research and Development and Chief Scientific Officer, said, "Based on these positive results, we believe that TAF has the potential to become a key component of next-generation single tablet regimens in HIV therapy. We are now completing enrollment of two Phase 3 clinical trials comparing a TAF-based regimen to Stribild in patients new to HIV treatment, and look forward t
'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Successful Clinical Trials, Recognitions, Enrollment in Studies, Product Launches, and Strategic Announcements - Research Report on Boston Scientific, Gilead, Abbott, Actavis, and Covidien
2. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
3. Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry
4. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
5. Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
6. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
7. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
8. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
9. Scioderm Announces Positive Phase II Data of Topical SD-101 on Wound Closure and Reduction of Lesions and Blisters in Children with Epidermolysis Bullosa (EB)
10. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
11. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... and consumables to the medical, research and veterinary markets, ... Chief Executive Officer, will present at the CL King ... Tuesday, September 9, 2014 at 12:30 p.m. ET. The ... Hotel in New York City . ...
(Date:8/29/2014)... 2014 Pixcelldata, the innovative Irish ... announced a major new deal with Dutch based eX-Path, ... expert, Dr. Marius Nap . The ... Congress of Pathology which is taking placing between August ... London where Pixcelldata will demonstrate its ...
(Date:8/29/2014)... Mass. , Aug. 29, ... PHG AEX: ... the  European Society of Cardiology ... is highlighting the full range of its cardiology solutions serving ... care continuum from prevention and diagnosis, ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
... 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: ... Stock Exchange (the "NYSE") has notified the Company that the ... requires a minimum average closing price of $1.00 per share ... the Company has six months from receipt of the notice ...
... Business Journal recently announced that eCardio Diagnostics ( www.ecardio.com ) ... included a distinguished list of 100 of the fastest growing ... ranked No. 17 with a two-year growth of 146.37%. This ... prestigious award. "There were so many inspiring companies ...
Cached Medicine Technology:American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard 2eCardio Among Honorees of the Houston Business Journal's Fast 100 List for Second Consecutive Year 2
(Date:8/30/2014)... NJ (PRWEB) August 30, 2014 The ... facilities in New Jersey and even in the U.S. ... that takes inches off of patients’ waists with deep-tissue ... cells in small sections, Vanquish is more inclusive to ... Patients lay comfortably under panels about one inch ...
(Date:8/30/2014)... After offering hyperbaric oxygen therapy ... past several years, Dr. Roy Schmidt and the ... a scholarship program for veterans who have been ... held this summer to discuss veterans’ needs ( ... shed light on the large number of veterans ...
(Date:8/30/2014)... Beach, Calif. (PRWEB) August 30, 2014 Insomnia ... Francis helps listeners understand how they unknowingly developed insomnia and ... have restful nights during. Tune in to the show ... The show airs live on August 30, and will ... more information on programming, go to DrCarolFrancisTalkRadio.com. , ...
(Date:8/30/2014)... PA (PRWEB) August 30, 2014 "My ... result of a car accident," said one of two ... muscle strain in her shoulder and neck area. She ... invented reduced pain and pressure, assisting in comfort and ... the patent-pending PILLOW CRADLE to support the head, neck ...
(Date:8/30/2014)... Bringing forth the great opportunities, India's ... Labor Day discount on all SEO services. While working ... services related to internet marketing. Their dedicated team of ... do have a deep understanding for their specialization. This ... and since the inception, they have worked with over ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, The Plastic Surgery Group 2Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2Health News:Profit By Search Announces Labor Day Discount on SEO Services 2
... difficult for doctors to tell whether a patient with ... inflammation, which can be treated with medicine. A new ... a U-M-led study. Ultrasound elasticity imaging, or UEI, ... inflammation and fibrosis, allowing patients to receive more appropriate ...
... State University of New York has received two grants ... of Health (NIH) to support neuroscience and pediatric pharmacology ... collaborative research network of SUNY,s four academic health centers ... both grants will be headquartered at SUNY Downstate Medical ...
... who experience new onset breast tenderness after starting combination ... cancer compared to women who don,t experience breast tenderness, ... Center has shown. One reason for this may be ... new onset tenderness was much more pronounced after initiation ...
... more effective than the current standard treatment. This is ... treatments, described by Thilo Schwandner and colleagues in the ... Dtsch Arztebl Int 2011; 108[39]: 653-60). In ... The problem is often caused by weakness of the ...
... 1982, alone in a laboratory, chemist Dan Shechtman looked ... He had discovered quasicrystals. But his groundbreaking findings ... years. On October 5, 2011, Shechtman received ... to stand by his research? What drove the men ...
... News) -- Teen drivers are 50 percent more likely to crash ... are after driving for a full year, according to a study ... drivers are nearly twice as likely to crash in the first ... the study found. However, parents can help teens prevent accidents ...
Cached Medicine News:Health News:Imaging technology might help doctors determine best treatment for Crohn's disease patients 2Health News:SUNY receives $4.3 million for research in neuroscience, pediatric pharmacology and vision 2Health News:SUNY receives $4.3 million for research in neuroscience, pediatric pharmacology and vision 3Health News:Breast tenderness in women getting combo hormone therapy associated with increase in breast density 2Health News:Breast tenderness in women getting combo hormone therapy associated with increase in breast density 3Health News:How and why did 2011 Nobel winner Dan Shechtman persist despite rejection? 2Health News:Teen Crash Risk High in First Month of Driving, Study Finds 2